Sabrina Aspra - Genomma Lab Director of International Operations, Director
| LABB Stock | MXN 15.08 0.32 2.08% |
Director
Ms. Sabrina Lucila Herrera Aspra serves as Director of Genomma Lab Internacional, S.A.B. de C.V. since 2017. She was the Company Director of International Operations since 2004 and was appointed as Member of the Company Board on March 24, 2011. She acted as Director of International Sales from 1998 to 2004. In the past, she worked at Posadas de Mexico, serving as Chief Financial and Administrative Officer. She holds a Bachelors degree in Information Technology from Universidad Anahuac and a Masters degree in Advanced Management from Colegio de Graduados de Alta Direccion. since 2017.
| Tenure | 7 years |
| Phone | 52 55 5081 0000 |
| Web | https://www.genommalab.com |
Genomma Lab Management Efficiency
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Maria Henry | Kimberly Clark de Mxico | 53 | |
| Jose Rodriguez | Kimberly Clark de Mxico | N/A | |
| Manuel Garza | Alfa SAB de | 66 | |
| Guillermo Hinojosa | Alfa SAB de | 68 | |
| Javier Cantu | Grupo Financiero Banorte | 54 | |
| Adrian Cueva | Grupo Financiero Banorte | 44 | |
| Javier Gomez | Gruma SAB de | 77 | |
| Salomon Russell | Gruma SAB de | 48 | |
| Jose Cordova | Kimberly Clark de Mxico | N/A | |
| Claudio Gonzalez | Alfa SAB de | 81 | |
| Esteban Fomperosa | Kimberly Clark de Mxico | 70 | |
| Ricardo Touche | Alfa SAB de | 71 | |
| Elane Stock | Kimberly Clark de Mxico | 52 | |
| Jorge Franco | Kimberly Clark de Mxico | 69 | |
| Rolando Saenz | Grupo Mxico SAB | N/A | |
| Fernando Mestre | Kimberly Clark de Mxico | 69 | |
| Jose Hernandez | Grupo Financiero Banorte | N/A | |
| Leonel Ramirez | Gruma SAB de | 63 | |
| Mayra Moreno | Gruma SAB de | 62 | |
| Homero Moreno | Gruma SAB de | 60 | |
| Hector Perez | Grupo Financiero Banorte | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 |
Genomma Lab Internacional Leadership Team
Elected by the shareholders, the Genomma Lab's board of directors comprises two types of representatives: Genomma Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genomma. The board's role is to monitor Genomma Lab's management team and ensure that shareholders' interests are well served. Genomma Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genomma Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maximo Juda, CEO, COO and Executive Vice-Pres | ||
| Scott Emerson, Independent Director | ||
| Stefano Curti, Global President of Brands | ||
| Cesar Lopez, Vice President of Global Marketing | ||
| Efran Crdova, Deputy Sec | ||
| Ramon Sastre, Executive Vice President of Institutional Relations | ||
| Carlos Alonso, Independent Director | ||
| Marianne Velasco, Global HR | ||
| Marco Munoz, Non-Member Secretary of the Board of Directors | ||
| Jorge Munoz, Independent Director | ||
| Ignacio Rodriguez, Independent Director | ||
| Alejandro Patino, Executive Vice President of Human Capital and Commercial Expansion | ||
| L Porres, Legal Officer | ||
| Leandro Gold, Independent Director | ||
| Jose Fernandez, Independent Director | ||
| Rodrigo Aspra, Chairman of the Board, Independent Director | ||
| Claudia Vettoretti, Vice-President of Marketing | ||
| Renata Aspra, COO and Executive Vice-Pres | ||
| Juan Gavito, Independent Director | ||
| Antonio Galland, Executive Vice President, Chief Financial and Chief Administrative Officer | ||
| Luis MacKissack, Director | ||
| Arturo Perez, Director | ||
| Hector Gonzalez, Independent Director | ||
| Burkhard Wittek, Director | ||
| Alejandro Patio, Media, Relations | ||
| Marco Sparvieri, Executive Vice-President of Global Sales | ||
| Javier Castilla, Independent Director | ||
| Engineer Galland, Exec CFO | ||
| Sabrina Aspra, Director of International Operations, Director | ||
| Mximo Juda, Advisor | ||
| Daniel Neria, Head Relations | ||
| Juan Alonso, Independent Director | ||
| Santiago Pelaez, Vice President of Industrial and Research and Development | ||
| Jorge Valderrama, Chief Executive Officer | ||
| Juan Sparvieri, Chief Operating Officer, Vice President | ||
| Roberto Sauma, Independent Director | ||
| Leticia Herrera, Global Director of Human Resources (Genomma Experience) |
Genomma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genomma Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 20.43 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 29.00 % | |||
| Shares Owned By Institutions | 29.10 % | |||
| Price To Earning | 13.61 X | |||
| Price To Book | 1.51 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Genomma Stock analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |